The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.

You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.

Become a Partner.

Country Product Indication Sponsor Date
Epoprostenol Replacement of heparin in patients requiring hemodialysis and who are at risk of hemmorrage Glaxo Wellcome Inc.;5 Moore Drive;Research Triangle Park, North Carolina, 27709 March 29, 1984
Ethanolamine oleate Esophageal varices QOL Medical;4445 North Highway A1A, 241;Vero Beach, Florida, 32963 March 22, 1984
Botulinum toxin type A Strabismus and blepharospasms Allergan, Inc.;2525 Dupont Drive, P.O. Box 19534;Irvine, California, 92713 March 22, 1984
Hemin Acute intermittent porphyria Abbott Laboratories;Diagnostics Division;Abbott Park, Illinois, 60064 March 16, 1984
Bacitracin Antibiotic-associated pseudomembranous enterocolitis caused by toxins A and B elaborated by Clostridium difficile A. L. Laboratories, Inc.;One Executive Drive, P.O. Box 1399;Fort Lee, New Jersey, 07024 March 13, 1984
Cromolyn sodium Mastocytosis Fisons Corporation;755 Jefferson Rd., P.O. Box 1710;Rochester, New York, 14603 March 8, 1984
Levocarnitine Genetic carnitine deficiency Leadiant Biosciences, Inc.;9841 Washingtonian Blvd, Suite 500;Gaithersburg, Maryland, 20878 February 28, 1984
Altretamine Advanced adenocarcinoma of the ovary Medimmune Oncology, Inc.;One Tower Bridge, 100 Front St., Suite 400;West Conshohocken, Pennsylvania, 19428 February 9, 1984
Alpha-1-antitrypsin (recombinant DNA Origin) As supplementation therapy for alpha-1-antitrypsin deficiency in the ZZ phenotype population Chiron Corporation;4560 Horton Street;Emeryville, California, 94608 January 1, 1984
Diaziquone Primary brain malignancies (grade III and IV astrocytomas) Warner-Lambert Company;2800 Plymouth Rd., P.O. Box 1047;Ann Arbor, Michigan, 48106 November 10, 1983
Trafermin in combination with plasma and platelet rich plasma Complex 4 mitochondrial respiratory chain deficiency HCell, Inc. 314 East Highland Mall Boulevard, Suite 406 Austin, Texas, 78752 January 1, 1970